Tipiracil hydrochloride

CAS No. 183204-72-0

Tipiracil hydrochloride( TPI )

Catalog No. M12823 CAS No. 183204-72-0

Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 68 In Stock
25MG 107 In Stock
50MG 146 In Stock
100MG 194 In Stock
200MG 251 In Stock
500MG 421 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tipiracil hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI).
  • Description
    Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TPI
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Nucleoside Antimetabolite/Analog
  • Recptor
    Nucleoside Antimetabolite/Analog
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    183204-72-0
  • Formula Weight
    279.12
  • Molecular Formula
    C9H12Cl2N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    Cl.ClC1=C(CN2CCCC2=N)NC(=O)NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yoshino T, et al. Lancet Oncol. 2012 Oct;13(10):993-100
molnova catalog
related products
  • DMT-2′Fluoro-dU Phos...

    DMT-2′Fluoro-dU Phosphoramidite can be used to modify nucleosides.

  • DFP-10917

    DFP-10917 (CNDAC, TAS-109) is a deoxycytidine analog with antitumor activity against various tumor cells.

  • Aspacytarabine

    Aspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti-?neoplastic agents for inhibiting cancer cell growth.